Epidemiology: Open Access
Open Access
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Recommended Conferences
Google Scholar citation report
Citations : 2820
Epidemiology: Open Access received 2820 citations as per Google Scholar report
Epidemiology: Open Access peer review process verified at publons
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- SafetyLit
- Access to Global Online Research in Agriculture (AGORA)
- Centre for Agriculture and Biosciences International (CABI)
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- CABI full text
- Cab direct
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Dr. Massoud Toussi
Dr. Massoud Toussi
Head of Epidemiology and Drug Safety
France
Tel:33 (6) 86 61 75 06
Biography
Massoud Toussi is Pharmacoepidemiology and drug safety lead for North Europe and Africa in IMS Health. He brings his knowledge and experience in medical, methodological and operational aspects of clinical and epidemiological research to guarantee the quality of interventional, observational and database studies. Massoud is medical doctor (M.D) with a Master of science MSc in medical informatics and health technology as well as a Doctor of Philosophy (PhD) in medical data analysis. He also holds a master of business administration (MBA) . He is a frequent lecturer in different professional conferences and is an active member of the International Society of Pharmacoepidemiology (ISPE), European Network of centers of Pharmacoepidemiology and Pharmacovigilance (ENCePP) and European Public Health Association (EUPHA). His domains of interest are pharmacoepidemiology, drug safety and the measurement of benefit-risk balance of drugs and health technologies. He has experience in most therapeutic domains with special interest in diabetes and psychiatry.
